ETHYL 2-(4-BROMO-2-CHLOROPHENOXY)ACETATE, 95.0%, 2g

1-isobutyl-1H-pyrazole-5-carboxylic acid, 95.0%, 1g

6-Bromo-5-methoxy-2-methyl-2H-indazole, 97%, 1g

4-(methylthio)-1,3,5-triazin-2-amine, 95.0%, 1g

N,N'-([1,1'-Biphenyl]-4,4'-diyl)diisonicotinamide, 98%, 250mg

2-(2,6-Dimethylcyclohex-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98+%, 250mg

dl-Alanine ethyl ester hydrochloride, 99.0%, 1g

N-tert-Butyl-2-chloroacetamide, 98.0%, 5g

4-Bromo-2-fluoro-3-methylaniline, 97%, 100mg

Infinity corrected plan phase S100x/1.25 objective. Working distance 0.18 mm

2,2'-Dibromo-9,9'-spirobi[fluorene], 97%, 100g

3,4-Dichlorobenzoic anhydride, 95.0%, 1g

3-Hydroxypyridine-2-carboxaldehyde, 98.0%, 250mg